Can Poor Liver Function Cause an Increase in Ammonia?
Yes, poor liver function directly causes elevated ammonia levels because the diseased liver cannot adequately metabolize ammonia through the urea cycle, and portosystemic shunting allows ammonia to bypass hepatic detoxification entirely. 1
Pathophysiologic Mechanism
Ammonia plays a central role in the pathophysiology of hepatic encephalopathy, and if a patient is normoammonemic, they do not have a sufficient degree of hepatic failure and/or portosystemic shunting to justify a working diagnosis of hepatic encephalopathy. 1
The mechanism involves two distinct processes:
Reduced hepatic clearance: Patients with cirrhosis demonstrate 20% lower whole-body ammonia clearance (2.7 L/min) compared to healthy persons (3.5 L/min), reflecting the diseased liver's diminished capacity to convert ammonia to urea. 2
Increased ammonia production: Cirrhotic patients exhibit nearly threefold higher ammonia production (131 μmol/min) compared to healthy individuals (49 μmol/min), driven by activated breakdown of glutamine in enterocytes and kidneys. 2, 3
Portosystemic shunting: Blood bypasses the liver through collateral vessels, preventing ammonia metabolism and causing systemic hyperammonemia even when residual hepatic function exists. 4
Clinical Significance and Diagnostic Value
A normal blood ammonia level has high negative predictive value, and normal ammonia in a patient with cirrhosis and delirium should prompt immediate investigation for other causes of delirium such as intracranial bleeding, septic encephalopathy, hyponatremia, or medication effects. 1, 5
Key diagnostic principles:
Ammonia measurement should be performed once at presentation in patients with delirium/encephalopathy and liver disease, as a normal value brings the diagnosis of hepatic encephalopathy into question. 1, 6
Blood ammonia levels correlate with the severity of hepatic encephalopathy, but patients without manifest hepatic encephalopathy and even without liver disease can display hyperammonemia. 1
Ammonia may remain elevated after clinical hepatic encephalopathy resolution, making serial measurements unreliable for monitoring treatment response. 1, 5
Prognostic Implications
Hyperammonemia is associated with decreased transplant-free survival from acute decompensation of cirrhosis, and ammonia levels in clinically stable outpatients predict future liver-related complications. 1, 7
Specific prognostic data:
Ammonia corrected to the upper limit of normal (AMM-ULN) independently predicts both liver-related complications (hazard ratio 2.13) and mortality (hazard ratio 1.45) in stable outpatients with cirrhosis. 7
Hospitalization rates increase in patients with ammonia levels 1.5 times the upper limit of normal, even with mild hyperammonemia. 1, 5
The AUROC of ammonia for predicting 1-year liver-related complications is 77.9%, which outperforms traditional severity scores like MELD. 7
Critical Measurement Considerations
Improper collection technique leads to falsely elevated results and renders the test useless. 5, 6
Essential collection protocol:
Collect from fasting patients when possible, as ammonia increases by 12% at 1 hour and 18% at 2 hours after a protein meal. 5, 8
Avoid venous stasis—do not use a tourniquet or allow fist clenching during blood draw. 5, 6
Process within 15 minutes and analyze immediately, as correlation between fresh and frozen samples is only modest (r = 0.62). 5, 8
Sample hemolysis falsely elevates results and invalidates the measurement. 5
Special Clinical Scenarios
Congenital portosystemic shunting should be investigated in patients with unexplained hyperammonemia, mental retardation, and/or clinical picture compatible with hepatic encephalopathy in the absence of cirrhosis. 4
Additional considerations:
For severe hyperammonemia (>100 µmol/L) with normal liver enzymes, consider inherited metabolic disorders, especially with family history of liver disease or neurological disorders. 5
Portosystemic shunting by bypassing the liver where ammonia is metabolized causes an increase in plasma ammonia that will ultimately affect cognition, even in patients without cirrhosis. 4
In acute liver failure with hepatic encephalopathy, arterial ammonia >200 μmol/L is associated with intracranial hypertension and poor neurological outcomes. 9
Common Pitfalls to Avoid
Do not assume hepatic encephalopathy based on elevated ammonia alone—the diagnosis requires clinical symptoms and exclusion of other causes. 6
Do not use ammonia trending to guide therapy—ammonia lowering is inconsistently associated with clinical treatment response, and ammonia levels are not used to monitor therapy. 1, 5
Do not delay treatment while waiting for ammonia results—hepatic encephalopathy is a clinical diagnosis requiring immediate empirical therapy with lactulose. 5
Do not overlook proper collection technique—site-specific ammonia upper limits differ significantly, and improper handling invalidates results. 6, 8